drugset / Trial / NCT07800897

A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants

NCT07800897 ↗

Phase 1 Recruiting 80 enrolled Bristol-Myers Squibb
Non-randomizedSequentialOpen-labelTreatment

Summary

The purpose of this study is to assess the food effect and drug interactions on drug levels of Navlimetostat in health adult female participants

Timeline

Start
2026-08-31
Primary completion
2027-03-25
Completion
2027-03-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule — —
Subject Midazolam Small molecule — —
Subject Navlimetostat Unknown — —
Subject Pantoprazole Other / unclassified — —
Subject Rifampicin Small molecule — —

Indications

No indication recorded.